Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc. Announces the Sale of Three Pharmacies to Executive Health Care; Sales Commissions on digiRX Prescriptions Fulfillment Continue
| Source: digiMedical Solutions, Inc.
DALLAS, TX--(Marketwire - August 13, 2008) - As part of the Company's transition from a
pharmacy company to a digital medical software company, digiMedical
Solutions, Inc. (PINKSHEETS : DGMS ) has completed the sale of three of its
Harrington's Acquisitions Inc.'s pharmacies, two located in Dallas, Texas,
and one located in Ft. Meyers, Florida, to Executive Health Care of
Wyoming. digiMedical is not selling the Company's proprietary digital
prescription handling software. Instead, digiMedical will receive
transaction based sales commissions for every prescription that is
fulfilled using digiRX software or digiReauth call center services
currently in use at these three pharmacies and surrounding physician
offices and clinics.
digiMedical is transitioning its business to focus on its suite of
proprietary software and reauthorization call center services provided to
doctors and pharmacies as the Company continues to grow its ecommerce
business model. The company plans to issue updates on the new business
focus in the coming weeks.
digiMedical provides digital prescription handling software that captures
and transmits prescriptions digitally from the physician's office to the
pharmacy, securely and in compliance with all DEA and HIPAA requirements.
The suite of software includes digiRX, digiRxStream, digiReauth,
digiRxComp, and digiAccounting.
Company Updates and Information
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to receive information on the company, please send
an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.™
digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and
medical technology company focused on developing next generation digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The Company's digital prescription handling software captures and
transmits prescriptions digitally from the physician's office to the
pharmacy, securely and in compliance with all DEA and HIPAA requirements.
The suite of software includes digiRX, digiRxStream, digiReauth,
digiRxComp, and digiAccounting.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission for additional information and a
presentation of the risks and uncertainties that may affect the company's
business and results of operations.